concatameric LAG3Ig (Medexgen)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameconcatameric LAG3Ig (Medexgen)
Drug Alias NameCD223Ig (Medexgen)
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionLymphocyte activation gene 3 protein modulators
TargetsLymphocyte activation gene 3 protein
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedexgen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedexgen Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A